<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Metabolic disorders were characterized by intestinal inflammation and mucosal-barrier dysfunction, which facilitate the translocation of luminal toxicity into the host [
 <xref rid="pone.0218490.ref050" ref-type="bibr" class="xref">50</xref>]. An HFD clearly damages intestinal barrier function and downregulates the major goblet cell mucin producing gene 
 <italic class="italic">Muc2</italic>, antimicrobial gene 
 <italic class="italic">Reg3g</italic> [
 <xref rid="pone.0218490.ref051" ref-type="bibr" class="xref">51</xref>], and tight junction proteins ZO-1 and occludin in mice [
 <xref rid="pone.0218490.ref052" ref-type="bibr" class="xref">52</xref>]. In contrast, the expression levels of these factors in the intestines were elevated by puerarin administration when compared to that in the HFD group (
 <xref ref-type="fig" rid="pone.0218490.g006" class="xref">Fig 6C, 6D and 6F</xref>), indicating that puerarin protected the integrity of the intestines.
</p>
